Understand who may be eligible for WATCHMAN FLX™ LAAC Implant
Identify which of your patients may benefit from the WATCHMAN FLX Implant
The WATCHMAN FLX Implant may be suitable for a broad range of non-valvular Afib (NVAF) patients and may be an appropriate option for your NVAF patients who meet these criteria. Eligible patients must:
- Have an increased risk for stroke and be recommended for anticoagulation (OAC)
- Be suitable for short-term oral anticoagulation*
- Have an appropriate reason to seek a non-pharmacologic alternative to OACs
*DAPT-only post-implant drug regimen now available.
Designed to treat a broad range of patient types
Previous bleed
A history of major or non‑major bleeding
Future bleed risk
A high risk of bleeding or at risk for falls
Lifestyle and occupation
Active lifestyle or occupation where anticoagulation is not ideal
Non-compliant
Prior inability to comply with OAC treatment
Drug interactions
Comorbidities requiring treatments that may not be compatible with OACs
Hear from real patients and how WATCHMAN has changed their lives
Wayne
Getting a WATCHMAN Implant has made a huge difference in Wayne’s life. Being very active, he immediately knew that the risks and side effects of blood thinners would hold him back from the life he wanted to live. After his implant procedure, he’s back to yoga, hiking and volunteering — all without the worries of bleeding or stroke.
Discover which of your NVAF patients may benefit from WATCHMAN
Download the WATCHMAN patient screening and referral form to help identify potential candidates and connect them with an implanter.
* DAPT-only post-implant drug regimen now available